Congress Looks to Beef up Agency’s Power to Withdraw Unproven AA Drugs
The House Energy and Commerce Committee is considering a pair of rival bills, one Democratic and one Republican, to reform the AA process.
Recent Headlines
Recent Headlines
Subscribe today for access to
Articles and Reports
Malpractice Premiums Rise but Medicare Reimbursement Doesn’t
...
Already a member? Log in here
How to Comply with Medicare Signature & Documentation Requirements
...
Already a member? Log in here
CMS Issues Reminders for Billing COVID-19 Specimen Collection & Symptom/Exposure Assessment
...
Already a member? Log in here
The Next Round of COVID-19 Legislation: What It Will Take to Prevent a Second Outbreak?
...
Already a member? Log in here
USPSTF Recommends Hepatitis C Virus Infection Screening for All Adults
...
Already a member? Log in here
FDA Finalizes CLIA Waiver Guidance for Approval of New In Vitro Diagnostic Devices
...
Already a member? Log in here
Billing & Coding: CMS Sets Rules for Medicare Coronavirus Testing Reimbursement with Private Payors Expected to Follow Suit
...
Already a member? Log in here
Reimbursement: Congress Calls on Insurers to Cover Coronavirus Testing without Charging Patients
...
Already a member? Log in here
LDTs: FDA Gets Tough with Non-Approved PGx Testing Claims
From - National Intelligence Report
The FDA has apparently set its enforcement sights on Laboratory Developed Tests (LDTs) that claim to predict…
- « Previous
- 1
- 2
- 3
- 4